P706: ASCIMINIB USE IN CML: THE UK EXPERIENCE
Author(s) -
Innes A.,
Orovboni V.,
Claudiani S.,
Fernando F.,
Khan A.,
Byrne J.,
Gallipoli P.,
Copland M.,
Horne G.,
Arnold C.,
Collins A.,
Cunningham N.,
Danga A.,
Frewin R.,
Garland P.,
Hannah G.,
Hassan S.,
Makkuni S.,
Rothwell K.,
Foroni L.,
Hayden C.,
Apperley J.,
Milojkovic D.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845708.96602.91
Subject(s) - medicine , ponatinib , kidney disease , nilotinib , myeloid leukemia , imatinib
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom